Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing
Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market
Michael Lehmann, executive vice president, global sales & marketing, Patheon shares his views on the challenges ahead for the pharma sector and how they could mean greater opportunities ahead for pharmaceutical manufacturers
James Cooper, Lime Associates, supply chain specialist, looks at how strengthening supplier relationships can help pharmaceutical manufacturers to protect their businesses in 2016
From pharmaceuticals to surgical equipment, every product made by the healthcare industry will be required to have a unique device identification (UDI) number. Richard Pether, Rotech, explains how healthcare suppliers can deal with implementation
